PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Highlights iLine Microsystems for Developing a Microfluidics-Based Sophisticated POC Device for PT/INR Coagulation Testing - The microINR system offers distinct advantages such as automatic calibration as well as multilevel quality control and low sample volume - ilinemicrosystems.com / Frost.com
Frost & Sullivan Highlights iLine Microsystems for Developing a Microfluidics-Based Sophisticated POC Device for PT/INR Coagulation Testing

 

NewswireToday - /newswire/ - Mountain View, CA, United States, 2016/10/03 - The microINR system offers distinct advantages such as automatic calibration as well as multilevel quality control and low sample volume - ilinemicrosystems.com / Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Based on its recent analysis of the prothrombin time/international normalized ratio (PT/INR) coagulation point of care (POC) market, Frost & Sullivan recognizes iLine Microsystems with the 2016 European Award for Enabling Technology Leadership. iLine Microsystems’ microINR system is poised to disrupt the POC PT/INR testing space with its lab on chip (LOC) approach. The device’s scalability and reliability, along with its ease of handling and multifunction quality control (QC) steps, make it the most cost-effective device for oral anticoagulant therapy (OAT) monitoring.

“The microINR system showcases iLine Microsystems’ expertise in hemostasis by employing LOC technology and applying microfluidics in the POC PT/INR testing space for both near patient testing and patient self-testing,” said Frost & Sullivan Senior Industry Analyst Divyaa Ravishankar. “This approach enables the integration of distinct biochemical tests in various channels within a single chip design, so that each channel has all the functionalities required to catalyze a reaction.”

The modular and integrated design of the microINR system comprises two components: a disposable microINR chip and a microINR meter. While the chip is used to hold the sample and the calibration information, the meter performs QC check and calibration reading. Additional Control checks are run in parallel to ensure test reliability, and results are displayed within 1 minute. This patented transformational technology for INR testing can store 200 test results and error logs, and provides an USB interface for transferring results to a desktop or an electronic health record (EHR).

The microINR system’s key benefits include:

• Microfluidic reaction. Microfluidics enable homogenous mixing by diffusion through the laminar flow generated by capillary reaction. Unlike peer devices and strips, the test is conducted under continuous blood flow.
• User friendliness. The process has minimal steps; for example, the device is automatically calibrated when the chip is inserted into the system, while all other INR devices require manual calibration.
• Low sample volume. The microINR is the only device that can function with a minimum sample volume of 3 μL by combining microfluidic principles with innovative chip design.
• Low reagent volume. The technology’s unique customization potential and the in-house production line tactics to dispense nanoliters of reagents has reduced the overall cost of production while keeping the biochemical properties and the integrity of the diagnostic reaction intact.

Other advantages of the microINR system include individual foil packaging for each chip to reduce bacterial contamination and rigorous QC protocols. Overall, it functions as a portable coagulometer with an embedded machine vision system that can mimic conditions of in-vivo hemostasis.

“The CE-marked microINR system has been cleverly designed to meet the needs of both centralized and decentralized settings,” Ravishankar said. “It enjoys huge popularity in key markets, and has gained very significant market share in Europe. Given the disruptive nature of its core technology, iLine Microsystems is looking to replicate its success in other POC market segments.”

Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing and leveraging new technologies, which influences both the functionality and the customer value of the new products and applications. The award lauds the high research and development spend on innovation, its relevance to the industry, and the positive effect on brand perception.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About iLine Microsystems
iLine Microsystems (ilinemicrosystems.com) has become a key player in the Point of Care diagnostic within the Hemostasis field after years of biomedical and biotechnological research and real market experience of proprietary Point of Care diagnostic solutions. iLine Microsystems was founded in 2007 with the aim to meet the needs of current and future healthcare models, improving the efficiency of healthcare professionals and patient’s quality of life.

The company designs and manufactures innovative Point of Care medical devices on the hemostasis field exploiting the advantages of both microfluidics and Lab-on-a-Chip technological concepts under the company's proprietary core technology.

Contact: Sofía Borrego
P:+34 943 005651 / F: +34 943 008737
E: sborrego[.]ilinemicrosystems.com

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Highlights iLine Microsystems for Developing a Microfluidics-Based Sophisticated POC Device for PT/INR Coagulation Testing

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Chiara Carella - Frost.com 
+44(0)20 7343 8314 chiara.carella[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System
SelectMDx to be Distributed Across Middle East by IPS Genomix
GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum
Saebo, Inc. Awarded Patent for Low-Profile Stroke Recovery Glove
GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration
Insulin Delivery Devices Market Size to Expand at 7% CAGR through 2020 Says PMR
Intubation Market Significant Profits Estimated to be Generated by 2025 Says Persistence Market Research
PMR Releases Report for Next Generation IV Infusion Pumps Market Impact of Existing and Emerging Market 2017-2025
Medical Tapes Market to Reach US$ 2Bn by 2024 Reports PMR
Global Pyrogen Testing Market Value Expected to Increase to US$ 1.37 Billion by 2024 Says PMR
Huber Needles Market Expected to Reach US$ 55M by 2024 According to PMR
ZOLL Technologies for Improving CPR Quality to be Showcased at NTI 2017
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
Biomarker-based Technologies to Disrupt Conventional Diagnosis in Diabetes Management across the Globe Finds Frost & Sullivan
Agfa Specialty Products Announces the Launch of UNIQOAT

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow Ltd

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)